BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20091941)

  • 41. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.
    Kopylov U; Levin A; Mendelson E; Dovrat S; Book M; Eliakim R; Ben-Horin S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):145-50. PubMed ID: 22612376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M; Boudailliez B
    Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
    Macartney K; McIntyre P
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001833. PubMed ID: 18646079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Varicella vaccination in pediatric oncology patients without interruption of chemotherapy.
    van de Wetering MD; Vossen MT; Jansen MH; Caron HN; Kuijpers TW
    J Clin Virol; 2016 Feb; 75():47-52. PubMed ID: 26780112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
    Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
    Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Varicella vaccination in Japan: necessity of implementing a routine vaccination program.
    Ozaki T
    J Infect Chemother; 2013 Apr; 19(2):188-95. PubMed ID: 23483311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination.
    Habermehl P; Lignitz A; Knuf M; Schmitt HJ; Slaoui M; Zepp F
    Vaccine; 1999 Feb; 17(7-8):669-74. PubMed ID: 10067672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Varicella vaccination in children with steroid-sensitive nephrotic syndrome.
    Alpay H; Yildiz N; Onar A; Temizer H; Ozçay S
    Pediatr Nephrol; 2002 Mar; 17(3):181-3. PubMed ID: 11956856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunization of healthy adults with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
    J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of varicella vaccine in Japan and future prospects.
    Ozaki T; Asano Y
    Vaccine; 2016 Jun; 34(29):3427-33. PubMed ID: 27160039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
    Wen SY; Liu WL
    Pediatrics; 2015 Mar; 135(3):e565-71. PubMed ID: 25713285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chickenpox party or varicella vaccine?
    Hambleton S; Arvin AM
    Adv Exp Med Biol; 2005; 568():11-24. PubMed ID: 16107063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Varicella vaccine: the American experience.
    Gershon AA; LaRussa P; Hardy I; Steinberg S; Silverstein S
    J Infect Dis; 1992 Aug; 166 Suppl 1():S63-8. PubMed ID: 1320652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.
    Sasadeusz J; Prince HM; Schwarer A; Szer J; Stork A; Bock HL; Povey M; Nicholson O; Innis BL
    Transpl Infect Dis; 2014 Dec; 16(6):1024-31. PubMed ID: 25272081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination of children with malignant disease against varicella.
    Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chickenpox.
    Hambleton S
    Curr Opin Infect Dis; 2005 Jun; 18(3):235-40. PubMed ID: 15864101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.